Develops a prediction model for lymph node metastasis in prostate cancer, suggesting reduced need for surgery.
Pelvic lymph node (LN) metastasis is a prognostic factor for prostate cancer; however, pelvic LN dissection (PLND) is associated with morbidity. Existing nomograms lack the integration of imaging variables as predictors of LN metastasis. We developed a model comprising clinical and imaging variables to predict LN metastasis. Data of patients who underwent robot-assisted radical prostatectomy for PLND were retrospectively analyzed. Preoperative variables included prostate-specific antigen (PSA) level, PSA density (PSAD), International Society of Urological Pathology (ISUP) grade, magnetic resonance imaging (MRI) T stage, and LN status assessed using both computed tomography and MRI. Logistic regression was performed to identify predictors. Model performance was evaluated using receiver-operating characteristic (ROC) analysis, calibration, bootstrap validation, and decision curve analysis. Among 123 patients, LN metastases were observed in 14 (11.4%). ISUP grade 5 (odds ratio [OR], 6.84; p = 0.002), MRI T stage ≥T3 (OR, 6.22; p = 0.004), and PSAD (OR, 3.91 per 0.5 ng/mL 2 increase; p = 0.008) were identified as independent predictors. The model integrating MRI T stage, ISUP grade, PSAD, and MRI LN status achieved an area under the ROC curve (AUC) of 0.903 and optimism-corrected AUC of 0.891. The LN positivity rate in a subgroup of low-risk patients, defined as MRI T stage ≤2, ISUP ≤2, PSAD ≤0.15, and MRI LN-negative (n = 13), was 0%. At a 6% predicted probability threshold, the model would avoid PLND in 69.7% of patients while missing one LN-positive case (1.2%). The AUC of the model (90.3%) was higher than that of nomograms developed by Partin, Briganti, and the Memorial Sloan Kettering Cancer Center in our cohort (84.3%, 83.5%, and 88.8%, respectively). The integrated model exhibited excellent predictive accuracy. This approach may enable the safe omission of PLND, reducing morbidity without compromising outcomes.
No takes yet. Share an insight, caveat, or question.
Yoon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: